×
A Novel Prognostic Metric Resolves the MYCN enigma in Silico and Points to a Biosynthetic Regulatory Shift Driven by MYCN Amplification in Neuroblastoma
Italia M., Parker M., Deignan R., Dercole F., Walker D., Wertheim K.
DOI
10.1101/2025.11.13.688307
Type
Preprint
Publication Date
2025-01-01T00:00:00+00:00